NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

結合型單株抗體的全球市場 (2020-2030年) :COVID-19的成長與變化

Conjugated Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change

出版商 The Business Research Company 商品編碼 977115
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 2-10個工作天內
價格
結合型單株抗體的全球市場 (2020-2030年) :COVID-19的成長與變化 Conjugated Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球結合型單株抗體市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區、國家的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 結合型單株抗體市場特徵

第3章 結合型單株抗體的市場規模、成長率

  • 全球市場的成果 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素
  • 全球市場的預測 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素

第4章 結合型單株抗體市場區隔

  • 世界市場區隔:各藥物,成果與預測 (以金額為準)
    • Adcetris
    • Kadcyla
  • 世界市場區隔:各技術,成果與預測 (以金額為準)
    • 開裂可能連接試劑
    • 非開裂可能連接試劑
  • 世界市場區隔:各應用領域,成果與預測 (以金額為準)
    • 血液癌症
    • 乳癌
    • 卵巢癌症
    • 肺癌症
    • 腦瘤
    • 其他

第5章 結合型單株抗體市場:各地區、國家分析

  • 全球市場的區分:各地區,成果與預測 (以金額為準)
  • 全球市場的區分:各國,成果與預測 (以金額為準)

第6章 亞太地區的結合型單株抗體市場

  • 市場概要
  • 市場區隔:各藥物,成果與預測 (以金額為準)
  • 市場區隔:各應用領域,成果與預測 (以金額為準)

第7章 中國的結合型單株抗體市場

第8章 印度的結合型單株抗體市場

第9章 日本的結合型單株抗體市場

第10章 澳洲的結合型單株抗體市場

第11章 印尼的結合型單株抗體市場

第12章 韓國的結合型單株抗體市場

第13章 西歐的結合型單株抗體市場

第14章 英國的結合型單株抗體市場

第15章 德國的結合型單株抗體市場

第16章 法國的結合型單株抗體市場

第17章 東歐的結合型單株抗體市場

第18章 俄羅斯的結合型單株抗體市場

第19章 北美的結合型單株抗體市場

第20章 美國的結合型單株抗體市場

第21章 南美的結合型單株抗體市場

第22章 巴西的結合型單株抗體市場

第23章 中東的結合型單株抗體市場

第24章 非洲的結合型單株抗體市場

第25章 市場競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Pfizer Inc.
    • F. Hoffmann-LA
    • Bristol -Myers Squibb
    • Merck & Co. Inc.
    • Immunomedics Inc.

第26章 主要的收購與合併

第27章 市場趨勢與策略

第28章 未來展望和潛在性分析

第29章 附錄

目錄

“Conjugated Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change ”from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global conjugated monoclonal antibodies market.

This report focuses on conjugated monoclonal antibodies market which is experiencing strong growth. The report gives a guide to the conjugated monoclonal antibodies market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the conjugated monoclonal antibodies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward?“ The Conjugated Monoclonal Antibodies market global report” from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider conjugated monoclonal antibodies market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The conjugated monoclonal antibodies market section of the report gives context. It compares the conjugated monoclonal antibodies market with other segments of the conjugated monoclonal antibodies market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, conjugated monoclonal antibodies indicators comparison.

Scope

Markets Covered:

  • 1) By Drugs: Adcetris; Kadcyla
  • 2)By Technology: Cleavable Linker; Non-cleavable Linker
  • 3) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumour; Others
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-LA; Bristol -Myers Squibb; Merck & Co. Inc.; Immunomedics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Conjugated Monoclonal Antibodies Market Characteristics

3. Conjugated Monoclonal Antibodies Market Size And Growth

  • 3.1. Global Conjugated Monoclonal Antibodies Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Conjugated Monoclonal Antibodies Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Conjugated Monoclonal Antibodies Market Segmentation

  • 4.1. Global Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Adcetris
  • Kadcyla
  • 4.2. Global Conjugated Monoclonal Antibodies Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Cleavable Linker
  • Non-cleavable Linker
  • 4.3. Global Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Blood Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Brain Tumour
  • Others

5. Conjugated Monoclonal Antibodies Market Regional And Country Analysis

  • 5.1. Global Conjugated Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Conjugated Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Conjugated Monoclonal Antibodies Market

  • 6.1. Asia-Pacific Conjugated Monoclonal Antibodies Market Overview
  • 6.2. Asia-Pacific Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Conjugated Monoclonal Antibodies Market

  • 7.1. China Conjugated Monoclonal Antibodies Market Overview
  • 7.2. China Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Conjugated Monoclonal Antibodies Market

  • 8.1. India Conjugated Monoclonal Antibodies Market Overview
  • 8.2. India Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Conjugated Monoclonal Antibodies Market

  • 9.1. Japan Conjugated Monoclonal Antibodies Market Overview
  • 9.2. Japan Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Conjugated Monoclonal Antibodies Market

  • 10.1. Australia Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Conjugated Monoclonal Antibodies Market

  • 11.1. Indonesia Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Conjugated Monoclonal Antibodies Market

  • 12.1. South Korea Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Conjugated Monoclonal Antibodies Market

  • 13.1. Western Europe Conjugated Monoclonal Antibodies Market Overview
  • 13.2. Western Europe Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Conjugated Monoclonal Antibodies Market

  • 14.1. UK Conjugated Monoclonal Antibodies Market Overview
  • 14.2. UK Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Conjugated Monoclonal Antibodies Market

  • 15.1. Germany Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Conjugated Monoclonal Antibodies Market

  • 16.4. France Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Conjugated Monoclonal Antibodies Market

  • 17.1. Eastern Europe Conjugated Monoclonal Antibodies Market Overview
  • 17.2. Eastern Europe Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Conjugated Monoclonal Antibodies Market

  • 18.1. Russia Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Conjugated Monoclonal Antibodies Market

  • 19.1. North America Conjugated Monoclonal Antibodies Market Overview
  • 19.2. North America Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Conjugated Monoclonal Antibodies Market

  • 20.1. USA Conjugated Monoclonal Antibodies Market Overview
  • 20.2. USA Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Conjugated Monoclonal Antibodies Market

  • 21.1. South America Conjugated Monoclonal Antibodies Market Overview
  • 21.2. South America Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Conjugated Monoclonal Antibodies Market

  • 22.1. Brazil Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Conjugated Monoclonal Antibodies Market

  • 23.1. Middle East Conjugated Monoclonal Antibodies Market Overview
  • 23.2. Middle East Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Conjugated Monoclonal Antibodies Market

  • 24.1. Africa Conjugated Monoclonal Antibodies Market Overview
  • 24.2. Africa Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Conjugated Monoclonal Antibodies Market Competitive Landscape And Company Profiles

  • 25.1. Conjugated Monoclonal Antibodies Market Competitive Landscape
  • 25.2. Conjugated Monoclonal Antibodies Market Company Profiles
    • 25.2.1. Pfizer Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. F. Hoffmann-LA
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Bristol -Myers Squibb
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Merck & Co. Inc.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Immunomedics Inc.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Conjugated Monoclonal Antibodies Market

27. Conjugated Monoclonal Antibodies Market Trends And Strategies

28. Conjugated Monoclonal Antibodies Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer